PFA
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Centenial Surgical Suture Ltd submitted its Q2 and H1 FY26 (ended September 30, 2025) unaudited standalone results alongside a Limited Review Report from its auditor. Revenue from operations came in at Rs 1,345.50 lakhs for the quarter, down from Rs 1,427.24 lakhs in Q2 FY25, while half-year revenue stood at Rs 2,639.11 lakhs versus Rs 2,800.97 lakhs a year ago. The company slipped into a loss before tax of Rs 1.20 lakhs in Q2 FY26 against a profit of Rs 16.91 lakhs last year, and H1 FY26 posted a small loss of Rs 5.11 lakhs against a profit of Rs 56.75 lakhs in H1 FY25. The full year FY25 had closed with a much larger loss of Rs 161.78 lakhs. The auditor issued an unmodified (clean) Limited Review Report on the results.
Revenue is declining year-on-year and the company has swung from profit to loss, signalling continued pressure on the medical devices business. Shareholders should note weakening top-line and the persistence of losses, which may weigh on the stock in the short term.